| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.7 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |